Literature DB >> 18826902

Community pharmacists' knowledge of and attitudes toward oral chemotherapy.

Cindy L O'Bryant1, Brian C Crandell.   

Abstract

OBJECTIVE: To assess community pharmacists' attitude toward and knowledge of oral chemotherapy (OC) in terms of drug indications, general dosing principles, drug interactions, adverse effects, and special handling precautions.
DESIGN: Descriptive, nonexperimental, cross-sectional survey.
SETTING: Colorado, Kansas, and the southeastern United States in May and June 2005. PARTICIPANTS: 1,080 pharmacists in four divisions of a large community pharmacy chain.
INTERVENTIONS: Web-based survey. MAIN OUTCOME MEASURES: Pharmacist knowledge of and attitude toward OC.
RESULTS: 243 surveys were returned (response rate 22.5%). Overall, pharmacists answered 49.7% of knowledge questions correctly. Pharmacists were most knowledgeable about general dosing principles (69%) and least knowledgeable about adverse effects (45%) and special handling (25%) of OC. Higher scores were seen for pharmacists who dispensed a greater number of OC prescriptions. Percentages of correct responses did not vary based on years of experience or number of OC continuing pharmacy education (CPE) programs attended. On a Likert-type scale of 1 (low) to 5 (high), the average comfort in dispensing OC was 2.4. On average, pharmacists indicated that knowing about OC was important to their practice (3.7) and expressed interest in participating in additional CPE programs on OC (4.2). Of respondents, 94.7% indicated that their pharmacy did not have a counting tray devoted to cytotoxic drugs.
CONCLUSION: This survey identified several areas in which pharmacists' knowledge of OC could be enhanced. Handling of OC is an area of important need, given the low number of pharmacists reporting separate counting trays for cytotoxic drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18826902     DOI: 10.1331/JAPhA.2008.07082

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  6 in total

Review 1.  Oral cancer chemotherapy: the critical interplay between patient education and patient safety.

Authors:  Thorvardur R Halfdanarson; Aminah Jatoi
Journal:  Curr Oncol Rep       Date:  2010-07       Impact factor: 5.945

2.  Medication adherence behaviors of Medicare beneficiaries.

Authors:  Sian M Carr-Lopez; Allen Shek; Janine Lastimosa; Rajul A Patel; Joseph A Woelfel; Suzanne M Galal; Berit Gundersen
Journal:  Patient Prefer Adherence       Date:  2014-09-17       Impact factor: 2.711

3.  Towards safety of oral anti-cancer agents, the need to educate our pharmacists.

Authors:  Sanaa Saeed Mekdad; Adher Dhaya AlSayed
Journal:  Saudi Pharm J       Date:  2015-06-23       Impact factor: 4.330

4.  Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme).

Authors:  Elise Deluche; Tiffany Darbas; Kevin Bourcier; Loic Montangon; Geraldine Bayard; Evelyne Caille; Julie Querrioux; Chantal Suchaud; Sonia Zabaleta; Sabine Chaput; Valerie Le Brun-Ly; Julia Pestre; Laurence Venat; Frédéric Thuillier; Elodie Nevado; Gaelle Maillan; Jeremy Jost; Sophie Leobon; Nicole Tubiana-Mathieu; Sandrine Lavau-Denes
Journal:  Med Oncol       Date:  2020-07-25       Impact factor: 3.064

5.  Estimating National-Level Exposure to Antineoplastic Agents in the Workplace: CAREX Canada Findings and Future Research Needs.

Authors:  Amy L Hall; Paul A Demers; George Astrakianakis; Calvin Ge; Cheryl E Peters
Journal:  Ann Work Expo Health       Date:  2017-07-01       Impact factor: 2.179

6.  Perceptions of Health-Care Workers of the Cost and Safety of Oral Oncolytic Agents for Patients: A Survey.

Authors:  Madeline Tompkinson; Kelly Fine; Dean Gruber; Ivo Abraham; Ali McBride
Journal:  J Adv Pract Oncol       Date:  2020-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.